Global Hepatitis C Virus (HCV) Antiviral Market Size By Product (HCV Antibody, HCV Viral Load), By Application (Diagnostic Centers, Hospitals, Home Use), By Geographic Scope And Forecast
Published on: 2024-08-03 | No of Pages : 320 | Industry : latest updates trending Report
Publisher : MIR | Format : PDF&Excel
Global Hepatitis C Virus (HCV) Antiviral Market Size By Product (HCV Antibody, HCV Viral Load), By Application (Diagnostic Centers, Hospitals, Home Use), By Geographic Scope And Forecast
Hepatitis C Virus (HCV) Antiviral Market Size And Forecast
Hepatitis C Virus (HCV) Antiviral Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2023 to 2030.
The increasing prevalence of infectious chronic diseases and a rising number of chronic diseases incidences are driving the growth of the global hepatitis C virus antiviral market. The Global Hepatitis C Virus (HCV) Antiviral Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
>>> Get | Download Sample Copy of Report @ –
Global Hepatitis C Virus (HCV) Antiviral Market Definition
Hepatitis C is a liver disease. This liver disease is caused by the hepatitis C virus also known as HCV. The virus is responsible for causing both acute and chronic hepatitis. The severity of the said diseases ranges from a mild illness lasting for a few weeks to a serious lifelong illness. Liver cancer is majorly caused by hepatitis C. It is a bloodborne virus that happens due to infection. This infection happens due to exposure to small quantities of blood. According to a report published by the World Health Organization (WHO), there are 71 million people across the globe suffering from the hepatitis C virus. The report further states that in 2016, approximately 399000 people died from hepatitis C.
Global Hepatitis C Virus (HCV) Antiviral Market Overview
The growth of the global Hepatitis C Virus (HCV) Antiviral Market is exponentially increasing owing to the increasing prevalence of infectious diseases and the rising number of incidents. In recent times, there have been increasing incidences of chronic infection with the hepatitis C virus and due to this demand for hepatitis C virus antiviral is increasing. Furthermore, government initiatives are helping to drive the growth of the market. Also, the increase in healthcare expenditure along with changing lifestyles is propelling the growth of the global Hepatitis C Virus (HCV) Antiviral Market.
However, some restraints are liming the growth of the global Hepatitis C Virus (HCV) Antiviral Market. The approval of hepatitis C virus (HCV) antiviral is too much of a hassle for companies. and The stringent rules and regulations for approvals of hepatitis c antivirals is expected to hinder the growth of the Global Hepatitis C Virus (HCV) Antiviral Market.
Global Hepatitis C Virus (HCV) Antiviral Market Segmentation Analysis
The Global Hepatitis C Virus (HCV) Antiviral Market is segmented based on Product, Application, and Geography.
Hepatitis C Virus (HCV) Antiviral Market, By Product
- HCV Antibody
- HCV Viral Load
- HCV Genotyping
Based on the Product, the market is bifurcated into HCV Antibody, HCV Viral Load, and HCV Genotyping. The antibody product segment dominates the market. The negative antibody test result shows that the person is not been infected with hepatitis C.
Hepatitis C Virus (HCV) Antiviral Market, By Application
- Diagnostic Centers
- Hospitals
- Home Use
Based on Application, the market is bifurcated into Diagnostic Centers, Hospitals, and Home Use. The hospital segment is contributing majorly to the market. The factors credit for the growth of the hospital segment are increased healthcare budgets and encouragement from the government.
Hepatitis C Virus (HCV) Antiviral Market by Geography
- North America
- Europe
- Asia Pacific
- Rest of The World
Based on Geography, the Global Hepatitis C Virus (HCV) Antiviral Market is classified into North America, Europe, Asia Pacific, and Rest of the world. The largest share in the market will be dominated by North America. The dominance of North American is credited to the increasing prevalence of the infectious disease. However, the Asia Pacific region is growing at a rapid pace owing to increasing incidences of hepatitis C. The china and India have emerged as the fastest-growing regional market,
Key Players
The “Global Hepatitis C Virus (HCV) Antiviral Market” study report will provide a valuable insight with an emphasis on the global market. The major players in the market are Roche Diagnostics, Abbott, Siemens, Qiagen, bioMérieux, Bio-Rad Laboratories, Meridian Bioscience, Vista Diagnostics, Biogate Laboratories, J.Mitra & Co. Ltd, Siemens Medical, and General Biologicals.
Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.
Key Developments
Partnerships, Collaborations, and Agreements
- On January 2020, Roche announced that it has entered into a 15-year, non-exclusive partnership with Illumina to broaden the adoption of distributable next-generation sequencing (NGS) based testing in oncology.
- On January 2018, GE Healthcare has entered into a strategic, long-term partnership with Roche to jointly develop and co-market digital clinical decision support solutions.
Mergers and Acquisitions
- On March 2021, Roche signs definitive merger agreement with GenMark Diagnostics, Inc., to access novel technology to test for broad range of pathogens with one patient sample.
- On September 2021, Roche signed a definitive share purchase agreement to acquire 100 percent of the outstanding shares of TIB Molbiol Group to enhance its molecular diagnostic solutions portfolio.
Product Launches and Product Expansions
- On March 2017, Siemens Healthineer’s Versant HCV Genotype 2.0 line probe (LiPA) assay gained market approval from U.S. FDA for HCV testing.
Report Scope
Report Attributes | Details |
---|---|
Study Period | 2018-2030 |
Base Year | 2021 |
Forecast Period | 2023-2030 |
Historical Period | 2018-2020 |
Key Companies Profiled | Roche Diagnostics, Abbott, Siemens, Qiagen, bioMérieux, Bio-Rad Laboratories, Meridian Bioscience, Vista Diagnostics. |
Segments Covered | By Product, By Application, and By Geography. |
Customization Scope | Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Top Trending Reports
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.